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Abstract 
Mucormycosis is a rare opportunistic fungal infection with a rapidly progressive and fulminant 
course with often fatal outcome. A less fulminant variety of this is the Rhino maxillary subtype 
which usually presents with palatal ulceration, facial swelling, turbinate necrosis and purulent 
sinusitis. We are reporting our experience of 4 such cases seen during the last 10 yrs. A strong 
suspicion, prompt diagnosis with pathological confirmation and aggressive surgical treatment 
gives a better outcome. 
Introduction 
Mucormycosis is an invasive fungal infection initiated in the nose and paranasal sinuses that 
frequently progresses to orbital and brain involvement. If recognized early, involvement is 
limited to the nasal cavity and paranasal sinuses. The purpose of this article is to report 4 cases 
of Rhino maxillary variety of mucormycosis, to emphasize the importance of early diagnosis, 
wide surgical debridement and systemic antifungal therapy in obtaining a favorable outcome. 
Case report 
Case 1 
A 62 year old female  reported to our department with complaints of pain and swelling in the left 
cheek for the past 1 month and ulcer in the palate for the past 15 days , gives  history of dental 
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extraction done 1 month back., History of  swelling around  left eye. Patient was a known case of 
type 2 diabetes mellitus for 2 years and on irregular treatment.  
 On examination, a diffuse swelling noted in the middle third of face on left side, which 
was warm and tender. On oral examination, upper lateral incisors were missing. Granulations 
noted along the alveolar  margin. Ulcerative lesion seen in the left half of hard palate of size 3x2 
cm and covered with yellowish slough and everted borders. Oroantral fistula seen.  
          Diagnostic nasal endoscopy was done , pus seen in middle and inferior meatus. Granular 
mass seen in left nasal cavity and pushing the septum towards opposite side, partly eroding and 
destroying it. Considering the patient’s medical history and a rapidly expanding ulcer involving 
palate and medial wall of maxilla , a provisional diagnosis of either osteomyelitis maxilla or 
mucormycosis was made.,even the possibility of malignant growth maxilla was considered . 
Patient had the following investigations. Blood sugar – 136 mg/dl, FBS – 180 mg/dl, PPBS – 
239 mg/dl, Blood urea – 20mg%, Creatinine – 0.6mgs%.  Hemogram showed  Hb – 10.4gms%, 
TC- 6800 cells/mm
3 
( P – 57%, L – 39%, E – 4%). ESR was 35 and 70mm at ½ hr and 1 hr 
respectively 
       Ulcerative lesion in palate                                             Granulation tissue alveolar margin      
                             
   
   DNE picture showing granulations                                     Septal perforation 
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 CT PNS showed diffuse radio- opacity of the left maxillary sinus and left nasal cavity 
with bony erosion ,palatal destruction with oroantral fistula. Patient was taken up for surgery 
and,wide Surgical debridement done including removal of part of the alveolar margin and medial 
wall of maxilla ., wide middle meatal antrostomy created. Necrotic material and granulation 
tissue removed from maxillary sinus.. Tthe materials were  sent for histopathological 
examination, which was reported as mucormycosis (Path No.1016/09 ). Patient started to show 
improvement from next day. Subsequently after HPE results, patient started on antifungal 
treatment (Tab.  Itraconazole 100mg bd for 1 month) and broad spectrum antibiotics (Inj. 
Ceftriaxone 1gm iv bd for 15 days and Inj. Gentamycin 80mg iv bd for 1 week). Patient’s 
diabetes controlled with Insulin.   
After 2 weeks post operatively, cheek swelling improved. Palatal lesion healing well. Normal 
lining of nasal mucosa started to appear. DNE done 3 weeks Post OP. Wound healing well, no 
granulations, antrostomy functioning well and oral antral fistula closed. Patient discharged and 
advised to control diabetes mellitus with Insulin treatment.Is disease free for past 2 yrs. 
 
 
 PreOP picture of  cheek swelling                                             PostOP picture at 2 weeks 
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  PostOP picture showing alveolar region            Histo Pathological picture  
 
Case 2 
A 52 yr old male presented with midline palatal ulcer 1 month duration, gives H/O swelling in 
midline palate with history of needle aspiration done elsewhere. He is a known Diabetic on 
irregular treatment and hypertensive. Clinical examination revealed 5 x 3 cm oval shaped ulcer 
in the palate more on left side exposing the bone. Left side cheek swelling and Paraesthesia 
present. 
Investigations revealed blood sugar 220 mg/dl. CT revealed opaque left maxillary sinus with 
palatal erosion. Biopsy reported as granulation tissue with fungal elements. Proceeded with 
partial maxillectomy /surgical debridement. HPE proved Mucormycosis. Itraconazole  was given 
for 3 wks and on adequate control of disease same was stopped. Wound healed well, pt was 
given an obturator and is disease free for past 6 yrs. 
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Picture showing palatal ulcer and necrotic alveolar margin 
 
CT Picture of case 2 
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Post op picture with obturator 
 
Case 3 
A 50 yr old male presented with swelling and numbness over the  rt cheek and upper lip for 6 
months, mucopurulent discharge over the alveolar  margin for 5 months. Gives H/O dental 
extraction of 3 tooth, and says he developed this problem following it. On clinical 
examination,mucopurulent discharge noted in floor of  rt nasal cavity, X ray PNS showed 
bilateral maxillary sinusitis, CT revealed oroantral fistula on  rt side. Biopsy reported as sub 
acute sinusitis with osteomyelitis with evidence of mucormycosis. Control of diabetes initiated 
and wide surgical debridement with sequestrectomy of devitalized floor of maxilla done.HPE 
confirmed mucormycosis. Pt was given obturator on dental opinion  and  is disease free . 
 
CT picture showing oroantral fistula 
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Defect after clearing the disease post op after 1 wk 
Case 4 
A 53 yr old male presented with ulcer in the palate for 1 yr. He had uncontrolled Diabetes.,gives 
H/O dental extraction. Clinical examination revealed  a large ulcerated lesion over the rt alveolar 
margin extending to the palate .CT revealed  oroantral fistula.Surgical debridement done,almost 
the entire floor of rt maxilla was unhealthy and was removed as a sequestrum.HPE of the 
specimen confirmed mucormycosis. This patient was better during the post op period,,was 
having problems with the interim obturator and was being attended by the dental department., 
was lost to our follow up . It was later known that this patient expired due to diabetes related  
renal complications. 
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Picture showing palatine defect 
       
patientt with obturator 
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Discussion 
Mucor mycosis is a rapidly progressive opportunistic infection caused by an organism of the 
family mucoraceae order mucorales class zygomycetes. These fungi are ubiquitous found in soil, 
bread molds,  decaying fruits and vegetables, usually are harmless and become pathogenic in 
man under certain conditions like immunosuppression, diabetic acidosis, antibiotic, steroids 
and cytotoxic therapy, with other predisposing factors like malignancy, burns, malnutrition, 
renal failure and blood dyscrasias.  The affinity for Diabetic patients is related to the fact that 
Rhizopus organisms thrive in an environment rich in glucose and an acid PH, because they have 
an active ketone reductase system, decreased phagocytic activity of polymorhonuclear 
leucocytes may also be a factor1. 
Upper airway mucormycosis was first described in 1885 by Paltauf, who coined the term 
Mycoris mucorina, which subsequently became Mucormycosis(2)(7) . Mucormycosis can infect 
the lungs, central Nervous System, Gastro intestinal tract and skin (burns patients ) but is 
known best for its rhinocerebral presentation, which is usually initiated with sinonasal 
involvement and may progress to the orbit and the brain2.  Rhinocerebral form is further  
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Showing cellophane tubule appearance,aseptate hyphae 
 
subdivided into two subtypes : a highly fatal rhinoorbitocerebral form which is invasive and may 
involve the ophthalmic and internal carotid arteries and a less fatal rhinomaxillary form which 
involves the sphenopalatine and greater palatine arteries, resulting in thrombosis of the 
turbinate and necrosis of the palate3. All our four cases belong to this group. 
Everyone is exposed to and inhales spores of the mucorales; the nasal ciliary clearance 
system,however transports these spores out of the nasal cavity, down the pharynx, to be 
cleared out by the gastrointestinal tract. Spores inhaled into the lungs are cleared by 
phagocytes. In the susceptible individual, the infection usually begins along the middle or 
inferior turbinate2. Depending on the degree of immunocompromise the disease process can 
be indolent or fulminant. Once the spores have entered the tissues, the organism becomes 
angioinvasive and has a predilection for the internal elastic lamina of the arteries. This invasion 
causes thrombosis, with secondary ischemic infarction and haemorragic necrosis. The organism 
thrives in the necrotic tissue and spreads by direct extension along injured blood vesssels1. 
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MEDICALLY IMPORTANT MEMBERS OF THE CLASS ZYGOMYCETES2 
Class                          Order                   Family                                Genus                               Species 
Zygomycetes         Mucorales                Mucoraceae                  Absidia* 
                                                                                                            Mucor* 
                                                                                                            Rhizomucor*                                
                                                                                                            Rhizopus*                             
oryzae(or                                               
                                                                                                                                                          Arrhizus)                                                                                                  
                                                        Cunninghamellaceae      Cunninghamella*                     
bertholetiae 
 
                                                        Mortierellaceae                      Mortierella*                            wolfii 
                                                           
                                                        Saksenaeacea                         Saksenaea* 
                                                         
                                                        Syncephalastraceae              Syncephalastrum elegans* 
 
                                                       Apophysomyceae 
                                                       Thamnidiaceae                          Cokeromyces 
 
                           Entomophthorales 
                                                        Ancylistaceae                            Delacroixia 
                                                                                                            Basidiobolus        
 
*Reported to have caused rhinocerebral mucormycosis. 
 
Involvement of the oral cavity usually appears as  palatal ulceration or necrosis and later as 
perforation of the palate as a result of infection in the nasal cavity or paranasal sinuses. 
Patients often exhibit facial cellulitis and anaesthesia, nasal discharge,necrotic turbinates, fever, 
headache and lethargy3. These findings were noted in our patients. 
Early and late cavernuous-carotid fistulas and mycotic aneurysms of the carotid have been 
reported. Patients should therefore be followed for sometime after the initial response to 
therapy1. 
Differential diagnosis of the lesion should include Squamous cell carcinoma, Chronic 
granulomatous infection like tuberculosis, tertiary syphilis, midline lethal granuloma and other 
deep fungal infections. 
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Radiographic analysis by routine radiographs may reveal clouding of multiple sinuses, mucosal 
thickening and bone erosion. CT better defines soft tissue invasion and necrosis, early bone 
erosion and cavernous sinus thrombosis.All our parients exhibited these findings with bone 
erosion and oroantral fistula. MR imaging, with or without gadolinium,is the best way of 
evaluating changes in major vessels, including carotid artery thrombosis and cavernous sinus 
thrombosis, and any intracranial extension. 
Once patient presents with above said findings, tissue diagnosis should be established with a 
biopsy to look for non septate hyphae representing fungal invasion. The best demonstration of 
the tissue invasive, nonseptate hyphae (cellophane tubules) is with silver methanamine stain1. 
As the disease progresses with alarming rapidity, early diagnosis, prompt and aggressive 
therapy is essential4. Successful treatment of mucormycosis consists of aggressive repeated 
surgical debridement of necrotic tissue, systemic antifungal therapy and immediate control of 
underlying systemic diseases. Correction of acidosis and hyperglycemia contributes to better 
survival rates. The fungus thrives in devitalized and necrotic tissue hence rigorous debridement 
is indicated1. Areas of ischemic tissue should also be removed because vascular thrombosis 
prevents chemotherapeutic agents from reaching the diseased tissues. 
In acute fulminant fungal sinusitis with invasion of blood vessels, amphotericin B has been 
considered the drug of choice( at a dose of 1 – 1.5 mg/kg per day ).There is now growing 
consensus that the newer lipid based formulations of the drug,in particular high doses of 
liposomal amphotericin B (10-15 mg/kg per day),should be adminmistered and be continued 
until the patient recovers5.Renal parameters have to be continually monitored.Other agents 
like Itrocanozole, Voriconazole and Posaconazole have been reportedly tried with varying 
results., however, the optimum dosage and duration of treatment have not been defined5.  
Itraconazole (100 mg bd) results in remineralization of the eroded skull base5 and is also said to 
prevent recurrence.The role of topical amphotericin B has not been studied systematically,but 
because of the small risk associated with administration it is often employed.( 50 mg vial of 
intravenous amphotericin B and 10 ml of sterile water, in a dosage of 4 ml in each nostril 2 to 6 
times daily). This can also be nebulized into the nose with a Rhinoflow device2. 
Hyperbaric oxygen therapy is theoretically attractive because it reverses the ischemic acidotic 
conditions that perpetuate fungal growth. Hyperbaric oxygen treatments are usually given at 
two atmospheres for 1 hour on a daily basis for upto 30 treatments. This may limit deformity by 
decreasing the required area of debridement6. 
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Conclusion 
Early diagnosis is important in the success of treatment. A patient presenting with nasal and 
palatal lesions, facial swelling or cellulits with history of dental extraction and being a known 
diabetic should immediately rise a suspicion of this dreadfull condition. Active surgical 
treatment with removal of all dead and necrotic tissue, control of diabetes and systemic 
antifungal therapy gives good results,reducing the mortality and morbidity due to 
mucormycosis. 
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